Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models.
<h4>Objectives</h4>Acquired coagulopathy may be associated with bleeding risk. Approaches to restore haemostasis include administration of coagulation factor concentrates, but there are concerns regarding potential prothrombotic risk. The present study assessed the prothrombotic potentia...
Main Authors: | Subhajit Ghosh, Wilfred Krege, Baerbel Doerr, Marcel Mischnik, Ingo Pragst, Gerhard Dickneite, Eva Herzog |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0258192 |
Similar Items
-
PB2651: A COMPARISON OF TIME TO TREATMENT WITH PROTHROMBIN COMPLEX CONCENTRATE: REMOTE OR POINT OF CARE STORAGE OF PCC
by: Samantha Bonney, et al.
Published: (2023-08-01) -
Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
by: Jing Tao, et al.
Published: (2018-06-01) -
The outcome of three-factor Prothrombin Complex Concentrate (3F-PCC) in warfarin reversal: A single center retrospective cohort study
by: Hock Peng Koh, et al.
Published: (2020-12-01) -
The Coagulation Factor XIIa Inhibitor rHA-Infestin-4 Improves Outcome after Cerebral Ischemia/Reperfusion Injury in Rats.
by: Jennifer Krupka, et al.
Published: (2016-01-01) -
Frequency of three prothrombotic polymorphisms among Syrian population: factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase C677T
by: Rami A. Jarjour, et al.
Published: (2017-01-01)